Excellent results from Sun Pharma - Views on News from Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  

Excellent results from Sun Pharma

May 2, 2000

Sun Pharma has declared excellent results for the year ended March 2000. While the turnover has increased by 35% and the net profits have grown 53%. Even if one were to take into account the turnover accruing in the current year of Rs 291 m due to the amalgamation of Gujarat Lyka, still the turnover has grown by 26% in a year when the domestic formulations have grown only by 9.2%.

(Rs m)FY1999FY2000Change
Sales 3,555.9 4,785.5 34.6%
Other Income 26.9 36.3 34.9%
Expenditure 2,848.7 3,717.5 30.5%
Operating Profit (EBDIT) 707.2 1,068.0 51.0%
Operating Profit Margin (%)19.9%22.3% 
Interest 49.3 14.4 -70.8%
Depreciation 86.6 126.9 46.5%
Profit before Tax 598.2 963.0 61.0%
Other Adjustments 12.0 -  
Tax 19.5 58.7 201.0%
Profit after Tax/(Loss) 590.7 904.3 53.1%
Net profit margin (%)16.6%18.9% 
Earnings per share* 38.3 19.6  

The company’s strategy of focussing on therapeutic areas such as oncology (anti–cancer), cardiology, gastro–enteritis has paid of immensely as evidenced by the growth in the topline and the improvement of operating margins. The company has written off the entire R & D expenses (Rs 15 m) incurred in the current year apart from a one time write off of Rs 40.7 m.

The stock quotes at Rs 358 currently at an earnings multiple of 18.31 times. The earnings have been taken on a fully diluted equity after a 2:1 bonus (2 shares for every one held).

Equitymaster requests your view! Post a comment on "Excellent results from Sun Pharma". Click here!


More Views on News

SUN PHARMA 2020-21 Annual Report Analysis (Annual Result Update)

Oct 22, 2021 | Updated on Oct 22, 2021

Here's an analysis of the annual report of SUN PHARMA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

Sun Pharma Zooms 10% as June Quarter Earnings Beat Estimates (Views On News)

Jul 30, 2021

Here's a rundown on Sun Pharma's June quarter results.

Sun Pharma's Stock Falls 4% After Its March Quarter Results (Views On News)

May 28, 2021

In the past three months, the stock has outperformed the market by gaining nearly 20%. Can it go higher?

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

More Views on News

Most Popular

Infosys vs TCS: Which is Better? (Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake (Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

6 Popular Stocks that Turned into Penny Stocks (Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

How to Find Your Next 10-Bagger in this Market (Profit Hunter)

Nov 19, 2021

The #1 make or break factor in your portfolio you shouldn't ignore.

MobiKwik IPO Opens for Subscription Soon. Key Things to Know Before Subscribing. (Views On News)

Nov 20, 2021

The Rs 19 bn issue is set to hit the market soon.


Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms


Dec 1, 2021 03:19 PM


  • Track your investment in SUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks